David A. Amato

机构：Eli Lilly (United States)

发表论文 59 篇 · 总被引 5414 次 · h-index 29

代表论文

• Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis (2016 · New England Journal of Medicine · 被引 848)
• Eszopiclone Co-Administered With Fluoxetine in Patients With Insomnia Coexisting With Major Depressive Disorder (2006 · Biological Psychiatry · 被引 477)
• Nightly Treatment of Primary Insomnia With Eszopiclone for Six Months: Effect on Sleep, Quality of Life, and Work Limitations (2007 · SLEEP · 被引 241)
• A 2-Week Efficacy and Safety Study of Eszopiclone in Elderly Patients with Primary Insomnia (2005 · SLEEP · 被引 145)
• A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome (2007 · Sleep Medicine · 被引 102)
• Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis (2019 · Journal of the American Academy of Dermatology · 被引 62)